CIPLA VALGANCICLOVIR valganciclovir (as hydrochloride) 450 mg tablet bottle

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

有效成分:

valganciclovir hydrochloride, Quantity: 496.3 mg (Equivalent: valganciclovir, Qty 450 mg)

可用日期:

Cipla Australia Pty Ltd

INN（国际名称）:

Valganciclovir hydrochloride

药物剂型:

Tablet, film coated

组成:

Excipient Ingredients: povidone; stearic acid; crospovidone; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000; iron oxide red

给药途径:

Oral

每包单位数:

60 tablets

处方类型:

(S4) Prescription Only Medicine

疗效迹象:

CIPLA VALGANCICLOVIR is indicated for the treatment of cytomegalovirus (CMV) retinitis in adult patients with acquired immunodeficiency syndrome (AIDS).,CIPLA VALGANCICLOVIR is indicated for the prophylaxis of CMV disease in adult and paediatric solid organ transplantation (SOT) patients who are at risk.

產品總結:

Visual Identification: Pink coloured, capsule shaped, biconvex film coated tablet plain on both sides; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

授权状态:

Licence status A

授权日期:

2016-09-02